èšåºæ®µéã®ãã€ãªãã¯ãããžãŒäŒæ¥ã§ãã Cabaletta Bio, Inc. ã¯ãB 现èåªä»æ§èªå·±å
ç«çŸæ£ã®æ£è
ã®ããã®äººå·¥ T 现èçæ³ã®çºèŠãšéçºã«éç¹ã眮ããŠããŸãããã®ç¬èªã®æè¡ã¯ãçŸæ£ã®åå ãšãªãèªå·±æäœãŸãã¯ç
åæ§ B 现èãç£çãã B 现èã«éžæçã«çµåããŠæé€ããããã«èšèšããããã¡ã©èªå·±æäœåå®¹äœ (CAAR) T 现èãå©çšããŠããŸããå瀟ã®äž»å補ååè£ã¯ DSG3-CAART ã§ãèªå·±å
ç«æ§æ°Žç±æ§ç®èçŸæ£ã§ããç²èå°åžžæ§å€©ç±ç¡ããã³ç¬¬ VIII å ååçš®æäœã䌎ãè¡åç
A ã®æ²»çè¬ãšããŠç¬¬ I çžèšåºè©Šéšäžã§ãããã®è£œååè£ãã€ãã©ã€ã³ã«ã¯ãéççç¡åçã®æ£è
ã®äžéšãæ²»çããããã®åèšåºæ®µéã®è£œåã§ãã MuSK-CAARTãè¡åç
A ã®æ£è
ã®äžéšãæ²»çããããã®çºèŠæ®µéã®è£œåã§ãã FVIII-CAART ãå«ãŸããŠããŸãããŸããç²èç®èå°åžžæ§å€©ç±ç¡ã®æ²»çè¬ãšããŠçºèŠæ®µéã®è£œåã§ããDSG3/1-CAARTãéçºããŠããŸããCabaletta Bio, Inc.ã¯ãã³ã·ã«ããã¢å€§åŠãšææºããŠãããã«ãªãã©ã«ãã¢å€§åŠçäºäŒãšç ç©¶å¥çŽãçµãã§ããŸããå瀟ã¯ä»¥åã¯Tycho Therapeutics, Inc.ãšããŠç¥ãããŠããŸãããã2018幎8æã«Cabaletta Bio, Inc.ã«ç€Ÿåã倿ŽããŸãããCabaletta Bio, Inc.ã¯2017幎ã«èšç«ããããã³ã·ã«ããã¢å·ãã£ã©ãã«ãã£ã¢ã«æ¬ç€Ÿã眮ããŠããŸãã